Stem Cell and Regenerative Medicine Lab, Beijing Institute of Transfusion Medicine, Beijing 100850, China.
South China Research Center for Stem Cell & Regenerative Medicine, Guangzhou 510005, China.
Biomed Res Int. 2017;2017:2320519. doi: 10.1155/2017/2320519. Epub 2017 Oct 19.
Platelets (PLTs) are produced by megakaryocytes (MKs) that completed differentiation and endomitosis. Endomitosis is an important process in which the cell replicates its DNA without cytokinesis and develops highly polyploid MK. In this study, to gain a better PLTs production, four small molecules (Rho-Rock inhibitor (RRI), nicotinamide (NIC), Src inhibitor (SI), and Aurora B inhibitor (ABI)) and their combinations were surveyed as MK culture supplements for promoting polyploidization. Three leukemia cell lines as well as primary mononuclear cells were chosen in the function and mechanism studies of the small molecules. In an optimal culture method, cells were treated with different small molecules and their combinations. The impact of the small molecules on megakaryocytic surface marker expression, polyploidy, proliferation, and apoptosis was examined for the best MK polyploidization supplement. The elaborate analysis confirmed that the combination of SI and RRI together with our MK induction system might result in efficient ploidy promotion. Our experiments demonstrated that, besides direct downregulation on the expression of cytoskeleton protein actin, SI and RRI could significantly enhance the level of cyclins through the suppression of p53 and p21. The verified small molecule combination might be further used in the in vitro PLT manufacture and clinical applications.
血小板(PLTs)由已完成分化和内有丝分裂的巨核细胞(MKs)产生。内有丝分裂是一个重要的过程,在此过程中,细胞在没有细胞分裂的情况下复制其 DNA,并发育成高度多倍体的 MK。在这项研究中,为了获得更好的 PLTs 产量,研究人员调查了四种小分子(Rho-Rock 抑制剂(RRI)、烟酰胺(NIC)、Src 抑制剂(SI)和 Aurora B 抑制剂(ABI))及其组合作为促进多倍体化的 MK 培养补充剂。在小分子的功能和机制研究中,选择了三种白血病细胞系和原代单核细胞。在最佳培养方法中,用不同的小分子及其组合处理细胞。研究了小分子对巨核细胞表面标记物表达、多倍性、增殖和凋亡的影响,以确定最佳的 MK 多倍体化补充剂。详细分析证实,SI 和 RRI 的组合与我们的 MK 诱导系统一起可能导致有效的倍性促进。我们的实验表明,除了直接下调细胞骨架蛋白肌动蛋白的表达外,SI 和 RRI 还可以通过抑制 p53 和 p21 显著提高细胞周期蛋白的水平。经过验证的小分子组合可能进一步用于体外 PLT 制造和临床应用。